UltraTouch starts Palpagraph breast mapping trials:
This article was originally published in Clinica
UltraTouch is starting clinical trials for a breast mapping technology, which it claims can map tumours 16 times smaller than those detected by hand - which are smaller than those routinely detected by mammography in premenopausal women. The Palpagraph scans the breast by computer-controlled mechanical palpation (light touch). It uses no radiation and is painless. The information is collected and stored in medical records as a standardised BreastMap. UltraTouch of Exton, Philadelphia, plans to use the clinical trial data to support applications to market the device in the US and Europe.
You may also be interested in...
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.